Medical Device Investing NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
Medical Device Investing NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society Annual Meeting
Medical Device Investing NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
Medical Device Investing NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Medical Device Investing NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
Tartisan Nickel Corp. Announces Rodren Drilling has Commenced Drilling at the Kenbridge Nickel Copper Cobalt Project, Sioux Narrows, Northwestern, Ontario
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value
